Cargando…
Glucose Metabolism After Renal Transplantation
OBJECTIVE: We determined prevalence, risk factors, phenotype, and pathophysiological mechanism of new-onset diabetes after transplantation (NODAT) to generate strategies for optimal pharmacological management of hyperglycemia in NODAT patients. RESEARCH DESIGN AND METHODS: Retrospective cohort study...
Autores principales: | Hecking, Manfred, Kainz, Alexander, Werzowa, Johannes, Haidinger, Michael, Döller, Dominik, Tura, Andrea, Karaboyas, Angelo, Hörl, Walter H., Wolzt, Michael, Sharif, Adnan, Roden, Michael, Moro, Ermanno, Pacini, Giovanni, Port, Friedrich K., Säemann, Marcus D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747896/ https://www.ncbi.nlm.nih.gov/pubmed/23656979 http://dx.doi.org/10.2337/dc12-2441 |
Ejemplares similares
-
A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation
por: Haidinger, Michael, et al.
Publicado: (2010) -
Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status
por: Antlanger, Marlies, et al.
Publicado: (2013) -
Comment on: Chakkera et al. Can New-Onset Diabetes After Kidney Transplant Be Prevented? Diabetes Care 2013;36:1406–1412
por: Hecking, Manfred, et al.
Publicado: (2013) -
Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
por: Schwaiger, Elisabeth, et al.
Publicado: (2019) -
Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial
por: Hecking, Manfred, et al.
Publicado: (2012)